Market Research Logo

Cancer/Tumor Profiling Market by Application (Diagnostic, Personalized Medicine, Research), Technique (Genomics, Proteomics, Metabolomics, Epigenetics),Technology (Next-generation Sequencing, qPCR, In-situ Hybridization, Microarray)- Forecast to 2021

Cancer/Tumor Profiling Market by Application (Diagnostic, Personalized Medicine, Research), Technique (Genomics, Proteomics, Metabolomics, Epigenetics),Technology (Next-generation Sequencing, qPCR, In-situ Hybridization, Microarray)- Forecast to 2021

“The global cancer/tumor profiling market is projected to grow at a CAGR of 10.7%.”
Global cancer/tumor profiling market is projected to reach USD 8.74 billion in 2022 from USD 5.26 billion in 2017 at CAGR of 10.7%. The cancer/tumor profiling market is primarily driven by the increasing number of cancer cases, growing utility of biomarkers in tumor profiling, and availability of funding for cancer research. In addition, the introduction and adoption of point-of-care diagnostic tests and development of personalized medicine are expected to offer growth opportunities for manufacturers of cancer/tumor profiling solutions. However, high capital investments and low benefit ratio of biomarkers are restraining the growth of this market.

“The immunoassays segment is expected to account for the largest share in 2017.”
On the basis of technology, the global cancer/tumor profiling market is broadly divided into immunoassays, hybridization, NGS, mass spectrometry, and other technologies. In 2017, the immunoassays segment is expected to account for the largest share of the cancer/tumor profiling technologies market. The high sensitivity and cost-effectiveness of these techniques as well as technological advancements in these immunoassays tests are factors that are expected to propel the growth of this market in the coming years. Furthermore, the hybridization technology is again divided on the basis of type which includes PCR, in-situ hybridization, and microarrays. The PCR segment is expected to account for the largest market share of hybridization technology in 2017. PCR is one of the most widely used technologies in the diagnostics market. This is primarily due to its ease of use, cost-effectiveness, quick turnaround time (4 to 6 hours), and easy availability of kits and reagents.

“The clinical application segment is expected to account for the largest share in 2017.”
Based on application, the cancer/tumor profiling market is categorized into clinical application, and research application. In 2017, the clinical application segment is expected to account for the largest share of the cancer/tumor profiling market. Technological advancements and the need for early diagnosis are further aiding market growth in this segment.

“North America is expected to account for the largest share in 2017.”
Among the four regions, North America is expected to account for the largest share of the cancer/tumor profiling market in 2017, followed by Europe, APAC, and the RoW. The large share of the North American market is mainly attributed to the increasing government support for discovery and development of biomarkers, increasing demand for personalized medicine, adoption of advanced omics technologies for biomarker discovery, and rising use of biomarkers in drug discovery and development by pharmaceutical companies in that region.

Break-up profile of primaries:
• By Company Type- Tier 1-45%, Tier 2-34% and Tier 3-21%
• By Designation- C-level-14%, D-level-10% and Others-76%
• By Region- North America-40%, Europe-32%, Asia Pacific-20%, and RoW-8%

The cancer/tumor profiling market is dominated by established players such as Illumina (US), QIAGEN (Netherlands), NeoGenomics Laboratories (US), HTG Molecular Diagnostic (US), and Genomic Health (US).

Research Coverage:
The cancer/tumor profiling market in this report is segmented by cancer type, application, technology, and region. The study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions, and profiles key players and core competencies in the cancer/tumor profiling market.

Reasons to buy this report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on portfolios offered by the top players in the global cancer/tumor profiling market. The report analyzes the market by function, solution, end user, and region

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global cancer/tumor profiling market

• Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for global cancer/tumor profiling products across regions

• Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global cancer/tumor profiling market

• Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global cancer/tumor profiling market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • MARKETS COVERED
    • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
      • KEY DATA FROM SECONDARY SOURCES
      • KEY DATA FROM PRIMARY SOURCES
      • ASSUMPTIONS FOR THE STUDY
    • MACROECONOMIC FACTOR ANALYSIS
      • INTRODUCTION
      • DEMAND-SIDE ANALYSIS
      • SUPPLY-SIDE ANALYSIS
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • CANCER/TUMOR PROFILING MARKET: MARKET OVERVIEW
    • GEOGRAPHIC ANALYSIS: CANCER/TUMOR PROFILING MARKET, BY TECHNIQUE (2016)
    • GLOBAL CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021
    • GLOBAL CANCER/TUMOR PROFILING MARKET SIZE, BY APPLICATION, 2016 VS. 2021
    • CANCER/TUMOR PROFILING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table LIST OF FDA-APPROVED BIOMARKERS FOR DIFFERENT TYPES OF CANCER
        • Table NATIONAL INSTITUTES OF HEALTH (NIH) SPENDING, BY TYPE OF CANCER (FINANCIAL YEAR 2015)
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • CANCER/TUMOR PROFILING MARKET, BY APPLICATION
    • INTRODUCTION
      • Table CANCER/TUMOR PROFILING MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
    • PERSONALIZED MEDICINE
      • Table CANCER/TUMOR PROFILING MARKET SIZE FOR PERSONALIZED MEDICINE, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: CANCER/TUMOR PROFILING MARKET SIZE FOR PERSONALIZED MEDICINE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table APAC: CANCER/TUMOR PROFILING MARKET SIZE FOR PERSONALIZED MEDICINE, BY COUNTRY, 2014-2021 (USD BILLION)
    • DIAGNOSTICS
      • Table CANCER/TUMOR PROFILING MARKET SIZE FOR DIAGNOSTICS, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: CANCER/TUMOR PROFILING MARKET SIZE FOR DIAGNOSTICS, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table APAC: CANCER/TUMOR PROFILING MARKET SIZE FOR DIAGNOSTICS, BY COUNTRY, 2014-2021 (USD BILLION)
    • BIOMARKER DISCOVERY
      • Table CANCER/TUMOR PROFILING MARKET SIZE FOR BIOMARKER DISCOVERY, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: CANCER/TUMOR PROFILING MARKET SIZE FOR BIOMARKER DISCOVERY, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table APAC: CANCER/TUMOR PROFILING MARKET SIZE FOR BIOMARKER DISCOVERY, BY COUNTRY, 2014-2021 (USD BILLION)
    • PROGNOSTICS
      • Table CANCER/TUMOR PROFILING MARKET SIZE FOR PROGNOSTICS, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: CANCER/TUMOR PROFILING MARKET SIZE FOR PROGNOSTICS, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table APAC: CANCER/TUMOR PROFILING MARKET SIZE FOR PROGNOSTICS, BY COUNTRY, 2014-2021 (USD BILLION)
    • RESEARCH APPLICATIONS
      • Table CANCER/TUMOR PROFILING MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: CANCER/TUMOR PROFILING MARKET SIZE FOR RESEARCH APPLICATIONS, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table APAC: CANCER/TUMOR PROFILING MARKET SIZE FOR RESEARCH APPLICATIONS, BY COUNTRY, 2014-2021 (USD BILLION)
  • CANCER/TUMOR PROFILING MARKET, BY TECHNIQUE
    • INTRODUCTION
      • Table CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD BILLION)
    • GENOMICS
      • Table CANCER/TUMOR PROFILING MARKET SIZE FOR GENOMICS, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: CANCER/TUMOR PROFILING MARKET SIZE FOR GENOMICS, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table APAC: CANCER/TUMOR PROFILING MARKET SIZE FOR GENOMICS, BY COUNTRY, 2014-2021 (USD BILLION)
    • PROTEOMICS
      • Table CANCER/TUMOR PROFILING MARKET SIZE FOR PROTEOMICS, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: CANCER/TUMOR PROFILING MARKET SIZE FOR PROTEOMICS, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table APAC: CANCER/TUMOR PROFILING MARKET SIZE FOR PROTEOMICS, BY COUNTRY, 2014-2021 (USD BILLION)
    • EPIGENETICS
      • Table CANCER/TUMOR PROFILING MARKET SIZE FOR EPIGENETICS, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: CANCER/TUMOR PROFILING MARKET SIZE FOR EPIGENETICS, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table APAC: CANCER/TUMOR PROFILING MARKET SIZE FOR EPIGENETICS, BY COUNTRY, 2014-2021 (USD BILLION)
    • METABOLOMICS
      • Table CANCER/TUMOR PROFILING MARKET SIZE FOR METABOLOMICS, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: CANCER/TUMOR PROFILING MARKET SIZE FOR METABOLOMICS, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table APAC: CANCER/TUMOR PROFILING MARKET SIZE FOR METABOLOMICS, BY COUNTRY, 2014-2021 (USD BILLION)
  • CANCER/TUMOR PROFILING MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD BILLION)
    • NEXT-GENERATION SEQUENCING (NGS)
      • Table NGS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: NGS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table APAC: NGS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD BILLION)
    • QUANTITATIVE POLYMERASE CHAIN REACTION (QPCR)
      • Table QUANTITATIVE PCR MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: QUANTITATIVE PCR MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table APAC: QUANTITATIVE PCR MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD BILLION)
    • IMMUNOHISTOCHEMISTRY (ICH)
      • Table IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table APAC: IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD BILLION)
    • IN SITU HYBRIDIZATION (ISH)
      • FLUORESCENCE IN SITU HYBRIDIZATION (FISH)
      • CHROMOGENIC IN SITU HYBRIDIZATION (CISH)
        • Table IN SITU HYBRIDIZATION MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
        • Table NORTH AMERICA: IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
        • Table APAC: IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD BILLION)
    • MICROARRAY
      • Table MICROARRAYS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: MICROARRAYS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table APAC: MICROARRAYS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD BILLION)
  • CANCER/TUMOR PROFILING MARKET, BY REGION
    • INTRODUCTION
      • Table CANCER/TUMOR PROFILING MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: CANCER/TUMOR PROFILING MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: CANCER/TUMOR PROFILING MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD BILLION)
      • U.S.
        • Table U.S.: CANCER/TUMOR PROFILING MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table U.S.: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD BILLION)
        • Table U.S.: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD BILLION)
      • CANADA
        • Table CANADA: CANCER/TUMOR PROFILING MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table CANADA: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD BILLION)
        • Table CANADA: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD BILLION)
    • EUROPE
      • Table EUROPE: CANCER/TUMOR PROFILING MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table EUROPE: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD BILLION)
      • Table EUROPE: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD BILLION)
    • ASIA-PACIFIC (APAC)
      • Table APAC: CANCER/TUMOR PROFILING MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
      • Table APAC: CANCER/TUMOR PROFILING MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table APAC: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD BILLION)
      • Table APAC: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD BILLION)
      • CHINA
        • Table CHINA: CANCER/TUMOR PROFILING MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table CHINA: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD BILLION)
        • Table CHINA: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD BILLION)
      • JAPAN
        • Table JAPAN: CANCER/TUMOR PROFILING MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table JAPAN: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD BILLION)
        • Table JAPAN: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD BILLION)
      • REST OF ASIA-PACIFIC
        • Table ROAPAC: CANCER/TUMOR PROFILING MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table ROAPAC: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD BILLION)
        • Table ROAPAC: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD BILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: CANCER/TUMOR PROFILING MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table ROW: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD BILLION)
      • Table ROW: CANCER/TUMOR PROFILING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD BILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • BATTLE FOR MARKET SHARE: PRODUCT LAUNCH WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS BETWEEN 2013 AND 2016
    • PRODUCT LAUNCHES
      • Table PRODUCT LAUNCHES, 2013-2016
    • AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
      • Table AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013-2016
    • ACQUISITIONS
      • Table ACQUISITIONS, 2013-2016
    • OTHERS STRATEGIES
      • Table OTHER STRATEGIES, 2013-2016
  • COMPANY PROFILES
    • INTRODUCTION
    • ILLUMINA, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • QIAGEN N.V.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • NEOGENOMICS LABORATORIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • HTG MOLECULAR DIAGNOSTICS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • GENOMIC HEALTH INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • CARIS LIFE SCIENCES
      • BUSINESS OVERVIEW
      • PRODUCTS & SERVICES OFFERED
      • RECENT DEVELOPMENTS
    • HELOMICS CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • NANOSTRING TECHNOLOGIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • OXFORD GENE TECHNOLOGY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • RIBOMED BIOTECHNOLOGIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS & SERVICES OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • OTHER DEVELOPMENTS
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report